The dynamics of primary progressive multiple sclerosis differ from tho
se of the more common secondary progressive form. The observation by M
RI that the frequency of enhancement with gadolinium-DTPA, a marker fo
r blood-brain barrier dysfunction, is significantly less in the primar
y progressive form, has led to the hypothesis that inflammation is les
s intense in this group. To test this, we have studied post-mortem mat
erial from nine cases judged from a retrospective analysis of case not
es to show clear clinical evidence of either primary progressive or se
condary progressive disease. Five hundred and seventy-eight lesions we
re analysed. There was significantly more inflammation in secondary pr
ogressive multiple sclerosis (as judged by the frequency of perivascul
ar cuffing and cellularity of the parenchyma) than in primary progress
ive disease. These observations have implications for therapeutic stra
tegies in progressive multiple sclerosis.